A number of studies have shown that NMO‐IgG, a specific anti‐AQP4 autoantibody produced in the humoral immune system by B cells, can be detected in most patients with NMO (Jarius & Wildemann, 2010) and is pathogenic. The gene discussed is AQP4; the disease is neuromyelitis optica.